MyFinsight
Home
About
Contact
Back
Income Statement
HERON THERAPEUTICS, INC. DE (HRTX)
source: myfinsight.com
Download
Download image
Comprehensive (loss) income
-$2,383K
Aponvie
$2,464K
CINVANTI
$24,143K
SUSTOL
$2,404K
ZYNRELEF
$8,189K
Net (loss) income
-$2,381K
Unrealized loss on
short-term investments
-$2K
Net product sales
$37,200K
(loss) income from
operations
-$1,637K
Other expense, net
-$744K
Gross profit
$27,343K
Cost of product sales
$9,857K
Total operating
expenses
$28,980K
General and
administrative
$14,471K
Research and development
$2,934K
Sales and marketing
$11,575K
Back